News Porton Pharma Solutions Ltd.

Equities

300363

CNE100001S57

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
16.37 ^CNY	-0.37%		-2.03%	-34.91%

Apr. 09	Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.	CI
Apr. 09	Porton Pharma Solutions Ltd.'s Equity Buyback announced on October 28, 2023, has closed with 1,260,000 shares, representing 0.23% for CNY 29.87 million.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.	Apr. 09	CI
Porton Pharma Solutions Ltd.'s Equity Buyback announced on October 28, 2023, has closed with 1,260,000 shares, representing 0.23% for CNY 29.87 million.	Apr. 08	CI
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.	Apr. 03	CI
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.	Jan. 03	CI
Porton Pharma Solutions Ltd. announces an Equity Buyback for CNY 30 million worth of its shares.	23-10-27	CI
Porton Pharma Solutions Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Porton Pharma Solutions Ltd. authorizes a Buyback Plan.	23-10-26	CI
Porton Pharma Solutions Ltd. agreed to acquire 30% stake in Hubei Yuyang Pharmaceutical Co., Ltd. for CNY73.5 million.	23-09-14	CI
Porton Pharma Solutions Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-18	CI
Porton Pharma Solutions Ltd. Announces Final Dividend for the Year 2022, Payable on 09 May 2023	23-04-28	CI
Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-21	CI
Porton Pharma Solutions Ltd. Approves Cash Dividend for the Year 2022	23-04-18	CI
Porton Pharma Sees Up to 25% Profit Drop in Q1 on Lower Orders	23-04-03	MT
Porton Pharma Solutions Ltd. Proposes Profit Distribution for 2022	23-03-27	CI
Porton Pharma Solutions Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-24	CI
Porton Pharma to Build 2.5 Billion Yuan Drug R&D, Production Facility	23-01-20	MT
China’s Porton to set up biotech park in Slovenia’s Menges	23-01-10	AQ
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on August 4, 2022.	22-11-22	CI
Porton Pharma Solutions Ltd.'s Equity Buyback announced on August 4, 2022, has closed with 2,022,344 shares, representing 0.37% for CNY 100 million.	22-11-20	CI
Shanghai Feiteng Pharmaceutical Technology Co., Ltd. announced that it has received CNY 60 million in funding from Porton Pharma Solutions Ltd.	22-10-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Porton Pharma Solutions Ltd.

Equities

300363

CNE100001S57

Summary

Filters